A1055 (2023-24 session)
NY State bill
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.
- Title
- Relates to the availability of buprenorphine in opioid treatment programs
- Type
- New York State Assembly bill
- Session
- 2023-24 session
- Status
- In Assembly Committee
- Latest action date
- 2024-01-03
- In committee
- Ways And Means
- Introduced
- 2023-01-13
- Same as
- S3347
- Law section
- Mental Hygiene Law
Sponsors
- Linda B. Rosenthal Assembly Member, District 67
Heard in committee
- Alcoholism and Drug Abuse NY State Assembly committee
- Ways and Means NY State Assembly committee
Same as
- S3347 (2023-24 session) NY State bill